Jerry Gurwitz to Polypharmacy
This is a "connection" page, showing publications Jerry Gurwitz has written about Polypharmacy.
Connection Strength
2.706
-
Rochon PA, Petrovic M, Cherubini A, Onder G, O'Mahony D, Sternberg SA, Stall NM, Gurwitz JH. Polypharmacy, inappropriate prescribing, and deprescribing in older people: through a sex and gender lens. Lancet Healthy Longev. 2021 05; 2(5):e290-e300.
Score: 0.726
-
Gurwitz JH. The physics of geriatric pharmacotherapy: overcoming therapeutic inertia and momentum. Am J Med. 2012 Jun; 125(6):523-4.
Score: 0.388
-
Willey CJ, Andrade SE, Cohen J, Fuller JC, Gurwitz JH. Polypharmacy with oral antidiabetic agents: an indicator of poor glycemic control. Am J Manag Care. 2006 Aug; 12(8):435-40.
Score: 0.261
-
Rochon PA, Li J, O'Mahony D, Onder G, Petrovic M, Sternberg SA, Gurwitz JH, Savage RD, Wu W, Giannakeas V, Kthupi A, Dalton K, McCarthy LM, Mason R, Giancola A, Borhani P, Cherubini A. The impact of age, sex, and gender on polypharmacy and potential prescribing cascades: Lessons from five databases. J Am Geriatr Soc. 2025 Feb; 73(2):520-532.
Score: 0.234
-
Gurwitz JH. Polypharmacy: a new paradigm for quality drug therapy in the elderly? Arch Intern Med. 2004 Oct 11; 164(18):1957-9.
Score: 0.230
-
Singh S, Cocoros NM, Li X, Mazor KM, Antonelli MT, Parlett L, Paullin M, Harkins TP, Zhou Y, Rochon PA, Platt R, Dashevsky I, Massino C, Saphirak C, Crawford SL, Gurwitz JH. Developing a PRogram to Educate and Sensitize Caregivers to Reduce the Inappropriate Prescription Burden in the Elderly with Alzheimer's Disease (D-PRESCRIBE-AD): Trial protocol and rationale of an open-label pragmatic, prospective randomized controlled trial. PLoS One. 2024; 19(2):e0297562.
Score: 0.220
-
Singh S, Cocoros NM, Haynes K, Nair VP, Harkins TP, Rochon PA, Platt R, Dashevsky I, Reynolds J, Mazor KM, Bloomstone S, Anzuoni K, Crawford SL, Gurwitz JH. Antidopaminergic-Antiparkinsonian Medication Prescribing Cascade in Persons with Alzheimer's Disease. J Am Geriatr Soc. 2021 05; 69(5):1328-1333.
Score: 0.178
-
Kapoor A, Field T, Handler S, Fisher K, Saphirak C, Crawford S, Fouayzi H, Johnson F, Spenard A, Zhang N, Gurwitz JH. Characteristics of Long-Term Care Residents That Predict Adverse Events after Hospitalization. J Am Geriatr Soc. 2020 11; 68(11):2551-2557.
Score: 0.173
-
Field TS, Mazor KM, Briesacher B, Debellis KR, Gurwitz JH. Adverse drug events resulting from patient errors in older adults. J Am Geriatr Soc. 2007 Feb; 55(2):271-6.
Score: 0.068
-
Gurwitz JH. An interview with Jerry Gurwitz. Interview by David Bates. Jt Comm J Qual Patient Saf. 2006 Dec; 32(12):667-71.
Score: 0.067
-
Simon SR, Chan KA, Soumerai SB, Wagner AK, Andrade SE, Feldstein AC, Lafata JE, Davis RL, Gurwitz JH. Potentially inappropriate medication use by elderly persons in U.S. Health Maintenance Organizations, 2000-2001. J Am Geriatr Soc. 2005 Feb; 53(2):227-32.
Score: 0.059
-
McCarthy LM, Savage R, Dalton K, Mason R, Li J, Lawson A, Wu W, Sternberg SA, Byrne S, Petrovic M, Onder G, Cherubini A, O'Mahony D, Gurwitz JH, Pegreffi F, Rochon PA. ThinkCascades: A Tool for Identifying Clinically Important Prescribing Cascades Affecting Older People. Drugs Aging. 2022 10; 39(10):829-840.
Score: 0.050
-
Wenger NK, Doherty CL, Gurwitz JH, Hirsch GA, Holmes HM, Maurer MS, Murray MD. Optimization of Drug Prescription and Medication Management in Older Adults with Cardiovascular Disease. Drugs Aging. 2017 11; 34(11):803-810.
Score: 0.036
-
Briesacher BA, Gurwitz JH, Soumerai SB. Patients at-risk for cost-related medication nonadherence: a review of the literature. J Gen Intern Med. 2007 Jun; 22(6):864-71.
Score: 0.017